Methionine Aminopeptidase 2/METAP2 Antibody (23GB2565)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-51160
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Knockdown Validated
Label
Unconjugated
Antibody Source
Monoclonal Rabbit IgG Clone # 23GB2565
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
A synthesized peptide derived from human Methionine Aminopeptidase 2/METAP2 (Uniprot: P50579)
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Methionine Aminopeptidase 2/METAP2 Antibody (23GB2565)
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Knockdown Validated
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.4), 50% glycerol
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: Methionine Aminopeptidase 2/METAP2
Alternate Names
Amp2, METAP2, MNPEP, p67eIF2
Gene Symbol
METAP2
Additional Methionine Aminopeptidase 2/METAP2 Products
Product Documents for Methionine Aminopeptidase 2/METAP2 Antibody (23GB2565)
Product Specific Notices for Methionine Aminopeptidase 2/METAP2 Antibody (23GB2565)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...